The FDA's refusal to review Moderna's application to sell a new flu shot is part of a pattern of regulatory U-turns and overruling of FDA staff by Vinay Prasad, head of the agency's vaccine division
ModernaModerna(US:MRNA) WSJ·2026-02-12 02:00

Group 1 - The head of the agency's vaccine division, Vinay Prasad, has made a decision that overrides objections from career staffers [1]

The FDA's refusal to review Moderna's application to sell a new flu shot is part of a pattern of regulatory U-turns and overruling of FDA staff by Vinay Prasad, head of the agency's vaccine division - Reportify